| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
|
|---|---|---|---|---|
| Total Revenue
|
986,010 | 886,719 | 686,630 | 521,983 |
|
Cost of Revenue
|
-604,904 | -541,272 | -405,557 | -352,778 |
|
Gross Profit
|
381,106 | 345,447 | 281,073 | 169,205 |
| Selling, General and Administrative Expenses
|
-205,890 | -169,460 | -143,726 | -114,183 |
|
Research and Development Expenses
|
-73,837 | -53,950 | -41,441 | -37,004 |
| Other Income/Expense, Operating
|
-57,320 | -51,636 | -48,937 | -42,642 |
|
Operating Income/Expenses
|
-337,047 | -275,046 | -234,104 | -193,829 |
|
Total Operating Profit/Loss
|
44,059 | 70,401 | 46,969 | -24,624 |
| Total Net Finance Income/Expense
|
-9,277 | -11,953 | -13,480 | -17,992 |
| Net Investment Income
|
-5,439 | 16,673 | -22,014 | 3,265 |
| Irregular Income/Expenses
|
-19,868 | -- | -- | -- |
|
Other Income/Expense, Non-Operating
|
-91,419 | -124,351 | -40,992 | -76,924 |
|
Non-Operating Income/Expenses, Total
|
-126,003 | -119,631 | -76,486 | -91,651 |
|
Pretax Income
|
-81,944 | -49,230 | -29,517 | -116,275 |
|
Provision for Income Tax
|
292,187 | -10,079 | -4,396 | -6,083 |
|
Net Income from Continuing Operations
|
210,243 | -59,309 | -33,913 | -122,358 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
210,243 | -59,309 | -33,913 | -122,358 |
|
Net Income after Non-Controlling/Minority Interests
|
210,243 | -59,309 | -33,913 | -122,358 |
|
Net Income Available to Common Stockholders
|
210,243 | -59,309 | -33,913 | -122,358 |
|
Dilution to Earnings
|
28,655 | -- | -- | -- |
|
Diluted Net Income Available to Common Stockholders
|
238,898 | -59,309 | -33,913 | -122,358 |
| Basic EPS
|
21.71 | -0.93 | -0.53 | -1.91 |
| Diluted EPS
|
5.10 | -0.93 | -0.53 | -1.91 |
|
Basic Weighted Average Shares Outstanding
|
64,025.94 | 64,025.94 | 64,025.94 | 64,025.94 |
|
Diluted Weighted Average Shares Outstanding
|
56,041.18 | 64,025.94 | 64,025.94 | 64,025.94 |
| Income Statement, Supplemental
|
||||
|
EBIT
|
-72,667 | -37,277 | -16,037 | -98,283 |
|
EBITDA
|
55,509 | 87,396 | 73,512 | 8,057 |
|
Normalized EBITDA
|
231,490 | 218,126 | 153,412 | 99,844 |
|
Normalized Income
|
264,207.11 | -68,500.65 | -7,048.26 | -114,053.52 |
12/31/2023 - 7/1/2026
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade